Cognizant's AI advancements, solid financials, and growth potential make it a strong buy for a diversified portfolio. See ...

Cognizant Technology Solutions has accused Infosys of misappropriating trade secrets from its healthcare software, TriZetto. In a court filing dated February 7, Cognizant stated that Infosys had ...

Plain Facts publishes a compilation of data-based insights with easy-to-read charts to help you delve deeper into the stories reported by Mint in the week gone by.